scispace - formally typeset
M

Manuel Zorzi

Researcher at University of Padua

Publications -  200
Citations -  8944

Manuel Zorzi is an academic researcher from University of Padua. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 36, co-authored 157 publications receiving 6682 citations. Previous affiliations of Manuel Zorzi include Baylor College of Medicine & University of Turin.

Papers
More filters
Journal ArticleDOI

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Claudia Allemani, +594 more
- 17 Mar 2018 - 
TL;DR: For most cancers, 5-year net survival remains among the highest in the world in the USA and Canada, in Australia and New Zealand, and in Finland, Iceland, Norway, and Sweden, while for many cancers, Denmark is closing the survival gap with the other Nordic countries.
Journal ArticleDOI

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

TL;DR: HPV-based screening is more effective than cytology in preventing invasive cervical cancer, by detecting persistent high-grade lesions earlier and providing a longer low-risk period, but in younger women, HPV screening leads to over-diagnosis of regressive CIN2.
Journal ArticleDOI

Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).

TL;DR: It is suggested that cancer patients have an increased risk of SARS-CoV-2 infections than non-cancer patients, however, prostate cancer patients receiving androgen-deprivation therapy (ADT) appear to be partially protected from Sars- CoV- 2 infections.
Journal ArticleDOI

Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test

TL;DR: The large relative sensitivity of HPV testing compared with conventional cytology and the difference between relative sensitivity during phases 1 and 2 suggests that there is frequent regression of CIN2+ that are detected by direct referral of younger HPV-positive women to colposcopy.